Follicular Lymphoma

Common Name(s)

Follicular Lymphoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Follicular Lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Follicular Lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Follicular Lymphoma" returned 768 free, full-text research articles on human participants. First 3 results:

A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population-Based Observational Data.
 

Author(s): Han-I Wang, Eve Roman, Simon Crouch, Eline Aas, Cathy Burton, Russell Patmore, Alexandra Smith

Journal: Value Health. 2018 10;21(10):1176-1185.

 

To use real-world data to develop a flexible generic decision model to predict cost, life expectancy, and quality-adjusted life-years (QALYs) for follicular lymphoma (FL) in the general patient population.

Last Updated: 31 Dec 1969

Go To URL
Counterpoint: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?
 

Author(s): Paul M Barr

Journal: Oncology (Williston Park, N.Y.). 2018 08;32(8):404, 407-9.

 

Last Updated: 31 Dec 1969

Go To URL
Point: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?
 

Author(s): Loretta J Nastoupil

Journal: Oncology (Williston Park, N.Y.). 2018 08;32(8):404-7.

 

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Follicular Lymphoma" returned 90 free, full-text review articles on human participants. First 3 results:

The promises and challenges of using gene mutations for patient stratification in follicular lymphoma.
 

Author(s): Oliver Weigert, David M Weinstock

Journal: Blood. 2017 09;130(13):1491-1498.

 

Follicular lymphoma (FL) is a clinically and molecularly highly heterogeneous disease. Most patients achieve long-lasting remissions and have excellent overall survival (OS) with current treatment. However, ∼20% of patients have early progression of disease and short OS. At present, ...

Last Updated: 31 Dec 1969

Go To URL
Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: Current controversies and advances.
 

Author(s): Narendranath Epperla, Mehdi Hamadani

Journal: Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):277-284.

 

Non-Hodgkin's lymphoma (NHL) constitutes a collection of lymphoproliferative disorders with diverse biologic, histologic, and clinical features. With a better understanding of the molecular pathogenesis, recently there have been major advances in the treatment of NHLs including addition ...

Last Updated: 31 Dec 1969

Go To URL
Unmet needs in the first-line treatment of follicular lymphoma.
 

Author(s): C Casulo, L Nastoupil, N H Fowler, J W Friedberg, C R Flowers

Journal: Ann. Oncol.. 2017 Sep;28(9):2094-2106.

 

For the majority of patients with newly diagnosed follicular lymphoma (FL), current treatments, while not curative, allow for long remission durations. However, several important needs remain unaddressed. Studies have consistently shown that ∼20% of patients with FL experience disease ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

A Pilot Study of a Personalized Neoantigen Cancer Vaccine Following Front-Line Rituximab in Follicular Lymphoma
 

Status: Not yet recruiting

Condition Summary: Follicular Lymphoma

 

Last Updated: 12 Mar 2018

Go to URL
TGR1202 in Relapsed and Refractory Follicular Lymphoma
 

Status: Recruiting

Condition Summary: Follicular Lymphoma

 

Last Updated: 8 Mar 2018

Go to URL